Title:
PHARMACEUTICAL COMPOSITION CONTAINING GEFITINIB, ADMINISTRABLE TO PATIENTS WITH LACTOSE INTOLERANCE AND HAVING IMPROVED DOSING CONVENIENCE
Document Type and Number:
WIPO Patent Application WO/2017/116031
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition containing gefitinib as a pharmaceutically active ingredient. When the present invention is prepared, the weight and the volume of the final formulation can be optimized in terms of dosing convenience for patients and can be administered to patients with lactose intolerance.
Inventors:
AHN BYUNG-NAK (KR)
MIN MI HONG (KR)
JEONG HYUN JUN (KR)
MIN MI HONG (KR)
JEONG HYUN JUN (KR)
Application Number:
PCT/KR2016/014300
Publication Date:
July 06, 2017
Filing Date:
December 07, 2016
Export Citation:
Assignee:
WHANIN PHARMACEUTICAL CO LTD (KR)
International Classes:
A61K9/00; A61K31/517; A61K31/5377; A61K47/26; A61K47/32; A61K47/36
Domestic Patent References:
| WO2010132431A1 | 2010-11-18 |
Foreign References:
| KR101002374B1 | 2010-12-17 | |||
| CN105168169A | 2015-12-23 | |||
| CN104586798A | 2015-05-06 | |||
| US20120156261A1 | 2012-06-21 |
Attorney, Agent or Firm:
PARK, Jong Hyeok (KR)
Download PDF: